Pharmaceutical company Lupin today informed the stock exchanges that it has appointed three new independent directors to its board. Lupin's board now constitutes of 12 members of which, 7 are independent non-executive directors.
The three new members include the non-executive Chairman of ICICI Bank, K V Kamath; Richard Zahn, former President of the German pharma major Schering Laboratories; and Dr Vijay Kelkar, a former Finance Ministry official.
"Lupin has always had an impeccable record of sound corporate governance, accountability and transparency, and this development further re-affirms our commitment to our shareholders and the society at large," Deshbandhu Gupta, Chairman of Lupin, said in a statement.